Willi Tarver | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Willi Tarver | Medicine and Dentistry | Best Researcher Award

Assistant Professor from The Ohio State University, United States

Dr. Willi L. Tarver is a distinguished Assistant Professor in the Division of Cancer Prevention and Control at The Ohio State University, where he leverages his interdisciplinary expertise to address disparities in healthcare delivery and cancer outcomes. With a strong foundation in public health informatics, behavioral oncology, and medical library sciences, Dr. Tarver’s research focuses on integrating patient-reported outcomes (PROs), electronic tools, and equity-focused interventions to better engage underserved populations in the cancer care continuum. His professional trajectory includes advanced fellowships in behavioral oncology and medical informatics, and he is actively involved in federally funded research projects. Dr. Tarver is also deeply committed to mentoring students and early-career professionals, especially from underrepresented backgrounds. His scholarly work addresses systemic issues in healthcare access and aims to develop scalable, tech-based strategies to reduce disparities. In addition to research and teaching, he plays key roles in administrative and clinical improvement initiatives within OSU’s Quality Improvement Hub. Dr. Tarver’s growing leadership within national organizations, innovative approach to equitable cancer prevention, and consistent focus on translating research into real-world applications position him as a leader in academic medicine and public health. He is a compelling nominee for the Best Researcher Award.

Professional Profile

Education

Dr. Tarver’s educational background reflects a unique and valuable combination of public health, information science, and communication, which together form the backbone of his interdisciplinary research. He earned his Doctor of Public Health (Dr.P.H.) from the University of Alabama at Birmingham, where he was also a recipient of the prestigious NCI Diversity Supplement under the Cancer Prevention and Control Training Program. Prior to this, he completed dual Master’s degrees in Public Health (MPH) and Library and Information Science (MLIS) at the University of South Florida. His foundational undergraduate training includes a B.A. in Communication from Columbus State University and an A.S. in Pre-Pharmacy from Gordon College. Dr. Tarver further sharpened his expertise through two postdoctoral fellowships: one in Behavioral Oncology at Indiana University and another in Medical Informatics at the VA Medical Center in Indianapolis. These fellowships provided him with advanced training in clinical research, data analytics, and healthcare system improvement. His broad and deep academic background allows him to bridge clinical research, informatics, and patient-centered interventions—a combination that has enabled his innovative work in cancer disparities and technology-enhanced health solutions.

Professional Experience

Dr. Tarver’s professional journey is defined by a blend of academic, clinical, and administrative roles that support his contributions to cancer prevention, health equity, and public health informatics. Currently serving as an Assistant Professor in the Division of Cancer Prevention and Control within the Department of Internal Medicine at The Ohio State University, he has held this role since 2019. Prior to this appointment, he was a postdoctoral and informatics fellow at the Roudebush VA Medical Center and Indiana University–Purdue University Indianapolis. During his time at the VA, Dr. Tarver contributed to the Center for Health Information and Communication, refining his expertise in applying informatics to support equitable healthcare delivery. His professional roles also extend into quality improvement, where he co-led the Health Equity Core at OSU’s Quality Improvement Hub from 2022 to 2024. Dr. Tarver is an active mentor in OSU’s Center for Cancer Health Equity Summer Research Program, guiding underrepresented students in impactful, community-focused projects. In addition, he participates in institutional governance as a member of OSU’s Innovation Council. Across his roles, he has demonstrated consistent leadership, interdisciplinary collaboration, and a deep commitment to improving health outcomes through equitable and data-driven approaches.

Research Interests

Dr. Tarver’s research is driven by a deep commitment to eliminating disparities in cancer prevention and control through the integration of technology, public health, and clinical practice. His primary interest lies in the development and evaluation of patient-centered technologies—particularly electronic patient-reported outcomes (ePRO) tools—to better engage underserved populations and inform health system decision-making. His projects explore how these tools can be tailored to the unique needs of minority communities, improve cancer survivorship planning, and enhance real-time communication between patients and providers. Another major area of interest is health equity, where Dr. Tarver investigates the impact of perceived discrimination, systemic biases, and cultural barriers on cancer care utilization and outcomes. Additionally, he is involved in research that evaluates educational interventions designed to reduce STEM-related biases in high school learning environments. Through his interdisciplinary work, Dr. Tarver aims to generate actionable insights that not only contribute to academic knowledge but also guide policy reforms and clinical practices. His interests span behavioral oncology, implementation science, and medical informatics, positioning him at the forefront of translational research that impacts patient lives while advancing health equity on a systemic scale.

Research Skills

Dr. Tarver possesses a robust skill set in both qualitative and quantitative research methodologies, which he applies to projects at the intersection of health equity, informatics, and cancer prevention. He is highly experienced in designing and analyzing patient-reported outcomes (PROs), particularly within underserved and minority populations. His expertise includes conducting structured interviews, participant observation, and systematic reviews—skills he actively shares as a guest lecturer in OSU’s Public Health Informatics course. Dr. Tarver is also proficient in research related to intervention development and evaluation, including randomized trials and implementation science frameworks. His grant-writing capabilities are demonstrated by his role as Principal Investigator (PI) and Co-Investigator (Co-I) on several federal and institutional research awards. He collaborates across disciplines, including clinical medicine, education, behavioral science, and information systems, to build comprehensive research designs. Additionally, he has applied informatics tools for data visualization, regulatory decision-making, and game-based learning assessments. These skills empower him to execute complex, multilevel projects with real-world applicability and high translational value. His research toolkit is complemented by strong mentorship abilities, fostering new talent and promoting equity-focused research within academic and clinical settings.

Awards and Honors

Dr. Tarver has received multiple prestigious honors that reflect his academic excellence, research promise, and commitment to advancing health equity. He was honored with the Young Investigator Award at the VA Medical Center in Indianapolis, recognizing his early-career contributions to cancer prevention research. His selection for the VA Advanced Fellowship in Medical Informatics further highlights his potential as a leader in data-driven health solutions. As a fellow in Behavioral Oncology at Indiana University, he gained national recognition for his work integrating psychological, behavioral, and technological approaches to patient-centered care. Notably, he was a recipient of the Diversity Supplement from the National Cancer Institute (NCI) through the University of Alabama at Birmingham, affirming his focus on minority health and health disparities. Earlier in his academic journey, he was awarded the ALSTARS Scholarship at the University of South Florida for academic merit and leadership. These accolades not only reflect his dedication to research excellence but also underscore the national recognition he has received for addressing some of the most pressing challenges in health equity, cancer care, and public health education.

Conclusion

In conclusion, Dr. Willi L. Tarver stands out as an exceptionally well-rounded and impactful academic professional whose contributions significantly advance the fields of cancer prevention, public health informatics, and health equity. His ability to bridge research, mentorship, education, and clinical innovation uniquely qualifies him for the Best Researcher Award. Through interdisciplinary training, funded research projects, and active mentorship, Dr. Tarver continues to address real-world health disparities and improve patient outcomes, particularly in underserved communities. His track record as a Principal Investigator and collaborator on diverse research grants highlights his leadership and collaborative capabilities. Moreover, his mentorship of minority students and involvement in institutional quality improvement initiatives reflect a long-term investment in both people and systems. With a growing portfolio of honors, active society memberships, and educational contributions, Dr. Tarver is positioned for continued excellence and recognition in the academic and public health communities. His work exemplifies the values of translational research, social impact, and scientific integrity, making him a deserving and distinguished candidate for the Best Researcher Award.

Publications Top Notes

1. Family structure and risk behaviors: the role of the family meal in assessing likelihood of adolescent risk behaviors
📅 Year: 2014
✍️ Authors: S. Goldfarb, W.L. Tarver, B. Sen
📰 Psychology Research and Behavior Management, pp. 53–66
📈 Citations: 83

2. The use of cancer-specific patient-centered technologies among underserved populations in the United States: systematic review
📅 Year: 2019
✍️ Authors: W.L. Tarver, D.A. Haggstrom
📰 Journal of Medical Internet Research, 21(4), e10256
📈 Citations: 68

3. Growth dynamics of patient-provider internet communication: trend analysis using the Health Information National Trends Survey (2003 to 2013)
📅 Year: 2018
✍️ Authors: W.L. Tarver, T. Menser, B.W. Hesse, T.J. Johnson, E. Beckjord, E.W. Ford, et al.
📰 Journal of Medical Internet Research, 20(3), e109
📈 Citations: 56

4. A systematic review of the association between family meals and adolescent risk outcomes
📅 Year: 2015
✍️ Authors: S.S. Goldfarb, W.L. Tarver, J.L. Locher, J. Preskitt, B. Sen
📰 Journal of Adolescence, 44, pp. 134–149
📈 Citations: 56

5. Exploring disparities and variability in perceptions and self-reported colorectal cancer screening among three ethnic subgroups of US Blacks
📅 Year: 2010
✍️ Authors: C.K. Gwede, C.M. William, K.B. Thomas, W.L. Tarver, G.P. Quinn, et al.
📰 Oncology Nursing Forum, 37(5), 581
📈 Citations: 51

6. A randomized trial to compare a tailored web-based intervention and tailored phone counseling to usual care for increasing colorectal cancer screening
📅 Year: 2018
✍️ Authors: V.L. Champion, S.M. Christy, W. Rakowski, W.G. Gathirua-Mwangi, W.L. Tarver, et al.
📰 Cancer Epidemiology, Biomarkers & Prevention, 27(12), 1433–1441
📈 Citations: 35

7. The impact of health information technology on cancer care across the continuum: a systematic review and meta-analysis
📅 Year: 2016
✍️ Authors: W.L. Tarver, N. Menachemi
📰 Journal of the American Medical Informatics Association, 23(2), 420–427
📈 Citations: 35

8. Perceptions of colorectal cancer among three ethnic subgroups of US blacks: a qualitative study
📅 Year: 2011
✍️ Authors: C.K. Gwede, E. Jean-Francois, G.P. Quinn, S. Wilson, W.L. Tarver, K.B. Thomas, et al.
📰 Journal of the National Medical Association, 103(8), 669–680
📈 Citations: 35

9. Allostatic load: a framework to understand breast cancer outcomes in Black women
📅 Year: 2021
✍️ Authors: S. Obeng-Gyasi, W. Tarver, R.C. Carlos, B.L. Andersen
📰 NPJ Breast Cancer, 7(1), 100
📈 Citations: 34

10. Factors associated with adherence to mammography screening among insured women differ by income levels
📅 Year: 2018
✍️ Authors: W. Gathirua-Mwangi, A. Cohee, W.L. Tarver, A. Marley, E. Biederman, et al.
📰 Women’s Health Issues, 28(5), 462–469
📈 Citations: 34

Xia Chen | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Ms. Xia Chen | Medicine and Dentistry |  Best Researcher Award

Professor from Yunnan Provincial Hospital of Chinese Medicine, China

Xia Chen is an accomplished chief physician, professor, and master’s supervisor, specializing in integrated Chinese and Western medicine, particularly in gastroenterology. Born in 1978 in Yunnan, China, she has devoted more than two decades to clinical practice, teaching, and scientific research. Currently, she serves as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at Yunnan Provincial Hospital of Chinese Medicine. She has gained recognition as an Outstanding Young Practitioner of Chinese Medicine in Yunnan Province and holds membership in the Hepatobiliary Disease Branch of the Chinese Medical Association. Her career focuses on the diagnosis and treatment of digestive diseases using both traditional Chinese medicine and Western medicine approaches. Xia Chen’s contribution extends beyond clinical work to research projects, drug trials, and academic publishing. Her ability to bridge traditional and modern medical practices has made her a notable figure in her field. Over the years, she has led and participated in numerous prestigious research projects and has authored or co-authored several scholarly works. Xia Chen’s career reflects dedication to improving healthcare outcomes through integrated medicine and advancing research in digestive health, making her a leader in her specialty and an inspiration for future researchers and clinicians.

Professional Profile

Education

Although detailed information about Xia Chen’s educational background is not explicitly provided, her current standing as a chief physician and professor suggests a comprehensive academic journey in medicine, likely beginning with a bachelor’s degree in traditional Chinese medicine or clinical medicine. Following her undergraduate studies, it is plausible she pursued further specialization, completing advanced degrees, possibly a master’s degree or doctorate, focusing on integrated Chinese and Western medicine with a specialty in digestive diseases. Xia Chen’s position as a master’s supervisor also indicates her formal academic qualification aligns with national standards for academic leadership roles in China, which typically require at least a master’s degree combined with significant clinical expertise. Her education would have provided her a strong foundation in traditional Chinese medical principles, combined with extensive training in modern clinical practices, pharmacology, and research methodology. Given her leadership in research projects and teaching, she likely continued her professional development through certifications, clinical fellowships, and continuous medical education programs. Her educational journey underpins her expertise in gastroenterology and serves as the backbone for her clinical, academic, and research excellence.

Professional Experience

Xia Chen has built a remarkable professional career, accumulating over 20 years of experience in clinical practice, teaching, and research in the field of integrated Chinese and Western medicine. She currently serves as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at Yunnan Provincial Hospital of Chinese Medicine. Her daily responsibilities include diagnosing and treating patients with complex digestive diseases, mentoring master’s students, and overseeing research activities. She has established herself as a specialist who skillfully combines traditional Chinese medical therapies with modern Western treatments, offering holistic and effective patient care. Xia Chen’s leadership extends to supervising clinical trials and participating in national Phase II, III, and IV drug research studies. Her practical skills are complemented by her academic contributions, which include teaching future healthcare professionals and guiding research initiatives. Furthermore, she actively contributes to healthcare policy improvements through her roles in professional associations such as the Hepatobiliary Disease Branch of the Chinese Medical Association. Her professional experience highlights her comprehensive expertise across clinical, academic, and scientific domains, making her a pivotal figure in advancing the integration of traditional Chinese medicine with contemporary medical science.

Research Interests

Xia Chen’s research interests focus on the integration of traditional Chinese medicine and Western medicine approaches to digestive diseases. A significant part of her work explores the therapeutic effects of natural medicines on intestinal dynamics. Her research aims to scientifically validate the efficacy of traditional remedies and their mechanisms of action, thereby bridging the gap between ancient practices and modern clinical science. Additionally, Xia Chen is deeply interested in clinical trials related to new drug developments, having participated in numerous national Phase II, III, and IV studies. Her research spans studying gastrointestinal motility disorders, chronic digestive conditions, and hepatobiliary diseases. She is particularly motivated by the desire to develop more effective, less invasive, and side-effect-minimized treatments through integrative approaches. Another important research area for Xia Chen is understanding how traditional Chinese formulations can complement or enhance the effects of Western pharmacological interventions. Her research is highly practical, patient-centered, and innovative, targeting improvements in clinical outcomes. With a growing emphasis on evidence-based medicine, her work contributes significantly to validating and modernizing traditional Chinese medicinal practices while maintaining their historical integrity and therapeutic richness.

Research Skills

Xia Chen possesses a broad range of research skills that have been instrumental in her professional success. She demonstrates expertise in designing and conducting clinical trials, especially those combining traditional Chinese medicinal approaches with Western methodologies. Her skill set includes protocol development, patient recruitment and management, data analysis, and reporting in accordance with national and international standards. She is proficient in evaluating the pharmacological effects of natural medicines and their applications in digestive health. Xia Chen’s publication record highlights her ability to carry out longitudinal studies and synthesize findings for publication in peer-reviewed journals. Her role as a master’s supervisor also reflects her ability to guide young researchers in research design, methodology, and thesis writing. Furthermore, her participation in over ten national drug studies indicates advanced skills in regulatory compliance, clinical pharmacology, and interdisciplinary collaboration. Xia Chen’s integrated approach to traditional and modern research paradigms exemplifies her unique strengths. Her research methodology is thorough, combining qualitative insights from traditional Chinese medicine with the quantitative rigor required in modern clinical research. These combined skills make her a formidable researcher capable of making impactful contributions to the field.

Awards and Honors

Throughout her distinguished career, Xia Chen has received notable awards and honors recognizing her professional and academic contributions. She has been named an Outstanding Young Practitioner of Chinese Medicine in Yunnan Province, an accolade that underscores her clinical excellence, research innovation, and contributions to the advancement of traditional Chinese medicine. Her appointment as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at the Yunnan Provincial Hospital of Chinese Medicine is itself a recognition of her expertise and leadership capabilities. Furthermore, her active membership in the Hepatobiliary Disease Branch of the Chinese Medical Association reflects national recognition of her skills and knowledge. These honors highlight her respected position within the Chinese medical community. They also affirm her commitment to bridging traditional Chinese medicine with modern clinical practices. While specific awards for research publications or international recognition have not been detailed, her extensive leadership in research projects and contribution to multiple monographs reinforce her academic and professional stature. Xia Chen’s awards and honors validate her significant and ongoing impact in the field of integrated medicine and gastroenterology.

Conclusion

Xia Chen is a highly accomplished clinician, educator, and researcher whose career embodies excellence in integrating traditional Chinese and Western medical practices. Her dedication to advancing digestive health through innovative, interdisciplinary methods sets her apart as a leader in her field. With over two decades of professional experience, leadership in major research projects, and numerous scholarly contributions, she has significantly impacted both clinical practice and academic research. Her recognition as an Outstanding Young Practitioner of Chinese Medicine and leadership roles within national medical organizations reflect her esteemed reputation. While opportunities exist for expanding her international research presence, Xia Chen’s current achievements already demonstrate her remarkable expertise, commitment, and influence. She serves as a bridge between ancient medical wisdom and contemporary science, promoting holistic and evidence-based healthcare solutions. As she continues to build on her impressive body of work, Xia Chen is poised to make even greater contributions to global medical science, ensuring that traditional Chinese medicine remains relevant, respected, and scientifically validated in the modern era.

Publications Top Notes

  • Title: Quercetin Inhibits Cardiomyocyte Apoptosis via Sirt3/SOD2/Mitochondrial Reactive Oxygen Species During Myocardial Ischemia–Reperfusion Injury

  • Authors: Xiong Da, Wang Xin, Wang Haiyu, Zhao Zicong, Ren Wenjun

  • Year: 2024

  • Citations: 6

Fei Liu | Medicine and Dentistry | Young Scientist Award

Published on by Shen Awards

Dr. Fei Liu | Medicine and Dentistry | Young Scientist Award

FeiDr. Fei Liu is a dedicated and emerging researcher affiliated with The Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University, China. His academic background is rooted in integrated traditional Chinese and Western medicine, with a research specialization in orthopedics. Dr. Liu has distinguished himself through his contributions to multiple research projects investigating the mechanisms of traditional Chinese medicine compounds and their therapeutic impact on orthopedic conditions. He is particularly focused on the pharmacological action of herbal formulas such as Duhuo Jisheng Tang, and their influence on pathways related to inflammation, apoptosis, and cellular metabolism. His scientific rigor is evident in his publication record, which includes six SCI-indexed journal articles (two as first author), and his involvement in several funded research grants at the provincial and municipal levels. Additionally, Dr. Liu holds a utility patent for an orthopedic surgical instrument, showcasing his commitment to clinical innovation. With a reputation for resilience, strong clinical foundations, and growing independent research capabilities, Dr. Liu is poised to make significant contributions to integrative medicine. Though early in his career, he has already demonstrated a promising trajectory, making him a strong candidate for emerging researcher recognition and a future contender for high-level scientific awards.

Professional Profile

Education

Dr. Fei Liu has pursued a comprehensive academic path in integrative medicine. He earned his undergraduate degree in Clinical Medicine of Integrated Traditional Chinese and Western Medicine from Hebei University of Chinese Medicine. This program laid a strong foundation in both conventional medical sciences and traditional Chinese therapeutic practices. Building upon this dual-focus education, he continued his studies at Southwest Medical University, where he undertook postgraduate training specializing in orthopedics within the same integrated clinical medicine discipline. His graduate research has centered on understanding the therapeutic mechanisms and efficacy of traditional herbal formulas used in orthopedic disorders. Dr. Liu’s educational experiences have provided him with a rare and valuable interdisciplinary skill set, enabling him to explore the complex biological interactions between traditional herbal compounds and modern biomedical systems. As a graduate student, he not only excelled academically—earning multiple prestigious scholarships—but also contributed actively to the academic community, serving as a student party committee member and engaging in various academic assistance roles. These educational milestones have shaped Dr. Liu into a well-rounded medical scientist with the tools to bridge traditional and modern medical practices effectively.

Professional Experience

Dr. Fei Liu’s professional journey has been primarily rooted in research and clinical training within the setting of Southwest Medical University and its affiliated hospital. During his postgraduate studies, he played significant roles in multiple ongoing research projects funded by the Sichuan Provincial Science and Technology Department, the Luzhou municipal government, and other institutional partnerships. He served as a second or third principal researcher on several studies investigating the pharmacological mechanisms of Duhuo Jisheng Tang and other herbal compounds in treating musculoskeletal disorders, particularly intervertebral disc degeneration. His work has involved both clinical observation and experimental design, contributing to tasks such as laboratory assay development, animal model experimentation, molecular analysis, and data interpretation. In parallel with his research activities, Dr. Liu has been involved in routine clinical work, managing patient admissions and performing basic surgical procedures such as internal fixation removals. His practical experience complements his scientific training, allowing him to integrate clinical insight with research innovation. Furthermore, he has actively participated in academic and administrative duties, serving within the student branch of the Party Committee and taking part in academic assistance programs. This balance of clinical proficiency and research engagement highlights his growing capacity as a clinician-scientist.

Research Interests

Dr. Fei Liu’s research interests lie at the intersection of traditional Chinese medicine (TCM) and modern biomedical science, with a particular focus on orthopedic applications. He is especially passionate about elucidating the pharmacological and molecular mechanisms underlying traditional herbal formulas, such as Duhuo Jisheng Tang, in the treatment of degenerative musculoskeletal conditions like intervertebral disc degeneration and osteoporosis. His projects have explored how these formulas influence biological pathways such as the JNK/P38MAPK signaling cascade, apoptosis (pyroptosis), glycolysis, and extracellular matrix degradation. Beyond musculoskeletal disorders, Dr. Liu has also contributed to interdisciplinary studies examining the immunological connections between COVID-19 and osteoporosis, and how m6A methylation affects prognosis and immunotherapy response in hepatocellular carcinoma. His holistic research approach integrates bioinformatics, in vivo and in vitro experimentation, and clinical data analysis. Dr. Liu is particularly interested in the potential of TCM to provide alternative therapeutic pathways with fewer side effects than synthetic drugs, especially when guided by modern research tools. His work contributes to the evolving field of integrative medicine, aiming to validate traditional knowledge using contemporary scientific methods and to promote evidence-based use of herbal treatments in modern clinical settings.

Research Skills

Dr. Fei Liu has developed a robust portfolio of research skills, well-suited to translational and interdisciplinary biomedical research. He possesses hands-on expertise in molecular biology techniques such as Western blotting, PCR, immunohistochemistry, and ELISA, which he has applied to study cellular signaling pathways in degenerative disc disease and related orthopedic conditions. In his various research projects, he has been actively involved in experimental design, animal modeling, data collection, statistical analysis, and manuscript preparation. Dr. Liu is also skilled in the use of bioinformatics tools for gene expression profiling and pathway analysis, which has allowed him to examine complex interactions between inflammation, immune response, and cellular metabolism. Additionally, he is familiar with biomechanical modeling, demonstrated by his collaborative work on lumbar spine simulations. His competence extends to academic writing, with several SCI-indexed journal publications, and to intellectual property development, as evidenced by his patent for a novel orthopedic surgical device. These combined skills reflect a balance of laboratory precision, analytical capability, and creative innovation. His ability to manage multiple research tasks while contributing meaningfully to both clinical and academic settings illustrates a strong foundation for continued scientific growth.

Awards and Honors

Throughout his academic career, Dr. Fei Liu has received several honors and recognitions that underscore his excellence in research and academic performance. He was awarded the National Second-Class Academic Scholarship for the 2020–2021 academic year and subsequently received the National First-Class Academic Scholarship for 2021–2022, highlighting his consistent academic distinction. In addition, he was honored with the “Kangzhe” Scholarship, a prestigious recognition of research potential in medical innovation. Dr. Liu has also been named an Outstanding Graduate Student of the 2020 cohort at his university, a distinction awarded to students demonstrating exceptional contributions in both research and leadership. His early commitment to scholarly excellence is further reflected in his participation as a student party committee member and his contributions to academic assistance initiatives. These accolades are not only a reflection of his academic abilities but also of his leadership qualities, dedication, and strong work ethic. They serve as indicators of his upward trajectory as a medical researcher and clinician. These honors reinforce his reputation as a promising young scholar, capable of making meaningful contributions to the field of integrative and orthopedic medicine.

Conclusion

In conclusion, Dr. Fei Liu exemplifies the qualities of a promising clinician-scientist whose work bridges traditional Chinese medicine and contemporary biomedical science. With a solid academic foundation, diverse professional experience, and a focused research agenda, he has contributed meaningfully to both experimental and translational studies. His involvement in several major research projects and his growing publication record demonstrate his potential for independent research leadership. Dr. Liu’s work not only advances understanding in the field of orthopedics but also enhances the scientific credibility of traditional medicine through rigorous investigation. He has already earned a patent, multiple scholarships, and recognitions that reflect his dedication and innovation. Although still in the early stages of his research career, he has established a strong foundation for future contributions at the national and international levels. With continued mentorship, expanded collaboration, and increased leadership in principal investigator roles, Dr. Liu is well-positioned to evolve into a leading figure in integrative medical research. His achievements to date make him a strong candidate for recognition in emerging researcher categories and a future contender for more senior scientific awards as his academic and professional journey progresses.

Publications Top Notes

Kandi Zhang | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Kandi Zhang | Medicine and Dentistry | Best Researcher Award

Doctor from Department of Cardiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, China

Dr. Kandi Zhang is an emerging medical researcher and clinician specializing in internal medicine with a primary focus on cardiology. Born in September 1993, she is currently affiliated with the Department of Cardiology at Shanghai Ninth People’s Hospital, which is part of Shanghai Jiao Tong University School of Medicine, one of China’s most prestigious institutions. Her clinical and research work reflects a strong dedication to advancing diagnostic and therapeutic methods for cardiovascular diseases, particularly through innovative applications of imaging technologies, antiplatelet therapies, and proteomic biomarker analysis. She has authored several peer-reviewed publications that explore the clinical and molecular aspects of acute coronary syndrome and myocardial infarction. Dr. Zhang’s combination of academic rigor and hands-on clinical expertise has allowed her to contribute meaningful insights to the field. Her collaborations with interdisciplinary teams and consistent publication in high-quality journals suggest a trajectory toward leadership in cardiovascular medicine. With a commitment to both patient-centered care and scientific discovery, she bridges the gap between medical innovation and clinical practice, positioning herself as a key contributor to the future of life sciences research in cardiology.

Professional Profile

Education

Dr. Kandi Zhang holds a Doctorate in Internal Medicine, earned through advanced medical education and research training at the Shanghai Jiao Tong University School of Medicine. This institution is internationally recognized for its rigorous curriculum, cutting-edge medical technology, and high-impact research environment. Her academic background provided her with comprehensive knowledge in physiology, pathology, pharmacology, and advanced clinical methodologies, with a particular concentration in cardiovascular medicine. During her doctoral studies, Dr. Zhang received mentorship from leading cardiologists and participated in clinical rotations and research initiatives at Shanghai Ninth People’s Hospital. The combination of theoretical education and practical exposure enabled her to specialize in both diagnosis and treatment of complex cardiac conditions. Her doctoral research likely involved extensive literature reviews, experimental design, clinical data analysis, and application of medical imaging and laboratory techniques. This educational foundation established her competence in evidence-based medicine, advanced diagnostics, and translational research. Through this training, she cultivated the analytical, technical, and clinical judgment skills required to contribute effectively to medical science. Her continuous engagement in academic publishing indicates that she has maintained a strong scholarly presence beyond her formal education, enriching her academic qualifications with real-world impact.

Professional Experience

Dr. Kandi Zhang’s professional experience is rooted in her role at the Department of Cardiology, Shanghai Ninth People’s Hospital, a highly respected clinical and research institution in China. As a practicing cardiologist and medical researcher, she is actively involved in both patient care and scientific inquiry. Her responsibilities include diagnosing and managing cardiovascular disorders, performing and interpreting diagnostic imaging, and participating in interdisciplinary case consultations. In parallel, she conducts clinical research with a focus on cardiovascular interventions, such as myocardial infarction management without reperfusion, left atrial appendage closure procedures, and the use of proteomic platforms to analyze biomarkers in acute coronary syndrome. Her position allows her to translate bedside observations into research hypotheses, bridging clinical care with data-driven innovation. Additionally, Dr. Zhang collaborates with colleagues across departments and institutions, contributing to multi-author research papers and bringing new insights to existing cardiology practices. Her dual engagement in research and clinical services provides a unique advantage, allowing her to contribute to real-time advancements in treatment protocols. This experience has also enhanced her leadership capabilities in conducting clinical trials, publishing scientific findings, and shaping evidence-based medical practices, making her a valuable contributor to both national and international cardiology communities.

Research Interest

Dr. Kandi Zhang’s research interests lie at the intersection of clinical cardiology, cardiovascular imaging, and molecular biomarker discovery. Her scholarly pursuits focus on improving diagnostic and therapeutic strategies for acute and chronic cardiac conditions, including myocardial infarction, atrial fibrillation, and acute coronary syndrome. She is particularly interested in the pre-treatment efficacy of antiplatelet medications in non-reperfused myocardial infarction cases, a subject with significant implications for emergency cardiac care. Another key area of her research involves comparative studies of imaging modalities for left atrial appendage closure—an essential technique for stroke prevention in atrial fibrillation patients. Her recent work has expanded into proteomics, exploring biomarker signatures in young patients with acute coronary syndrome, which opens possibilities for personalized medicine and early detection strategies. Dr. Zhang is committed to translational research that can swiftly impact clinical decision-making. By integrating data from various sources—including imaging, clinical trials, and molecular assays—her work advances the precision and effectiveness of cardiac interventions. She aspires to contribute to the development of non-invasive, cost-effective, and scalable diagnostics for cardiovascular diseases. Her research interests reflect a broader vision of integrating technology, biology, and clinical medicine to address pressing challenges in heart health globally.

Research Skills

Dr. Kandi Zhang possesses a robust set of research skills that complement her clinical expertise. Her methodological proficiency spans clinical trial design, statistical analysis, medical imaging evaluation, and biomarker identification using proteomics. She is adept at using various imaging techniques to support therapeutic interventions, as evidenced by her publication on evaluating orifice diameters for atrial appendage closure. Her familiarity with experimental protocols, animal models, and in vitro assays—such as her work on myocardial infarction in mice—demonstrates her versatility in both basic and applied research. She also shows skill in bioinformatics and data interpretation, especially in translating proteomic findings into clinically relevant insights. Furthermore, she has strong experience in scholarly writing, data visualization, and peer-reviewed publishing, which are essential for knowledge dissemination and academic contribution. Her ability to work collaboratively on multi-author projects highlights her communication and teamwork skills, crucial for multidisciplinary research environments. Dr. Zhang is also proficient in integrating patient data with clinical outcomes, allowing for a nuanced understanding of treatment efficacy. These research skills enable her to contribute to innovative, evidence-based practices in cardiology, and position her as a strong candidate for collaborative projects across the life sciences and medical research domains.

Awards and Honors

While specific named awards are not explicitly listed in the available profile, Dr. Kandi Zhang’s consistent publication in high-impact, peer-reviewed journals and affiliation with a top medical university suggest academic excellence and institutional recognition. Being a first or lead author in multiple scientific papers published in journals such as Cardiology Journal, Clinical Cardiology, and Frontiers in Cardiovascular Medicine indicates that her work is well-regarded within the cardiology and life sciences communities. Such scholarly visibility often accompanies internal honors such as best researcher accolades, conference recognitions, or research funding awards within the academic medical network. Her role at Shanghai Ninth People’s Hospital—a center for high-level research and patient care—also implies that she has undergone competitive selection processes and met stringent performance standards. Moreover, her early-career contributions, particularly in bridging clinical and molecular research, may position her for future international awards in cardiovascular research and life sciences innovation. If she continues on this trajectory, it is likely that formal recognitions and honors will follow as her influence in the field expands.

Conclusion

Dr. Kandi Zhang exemplifies the qualities of an innovative and impactful researcher in the field of life sciences, particularly in cardiovascular medicine. Through a combination of clinical practice, rigorous academic training, and a solid research portfolio, she has established herself as a credible and forward-thinking contributor to cardiology. Her studies on antiplatelet drug efficacy, imaging modality optimization, and proteomics-based biomarker identification highlight her commitment to solving real-world health challenges through science. While her profile would benefit from broader international exposure and interdisciplinary collaboration, her current achievements mark her as a rising figure in translational cardiovascular research. With continued effort and strategic partnerships, she is well-positioned to lead impactful projects that could redefine patient care standards in cardiology. As she advances in her career, Dr. Zhang has the potential to influence both academic and clinical landscapes, making her a strong candidate for recognition through life sciences innovation awards and future leadership roles in global medical research.

Publications Top Notes

  • Does Spontaneous Echo Contrast in the Left Atrial Appendage Increase Thromboembolism Risk After Left Atrial Appendage Closure? A Retrospective Study on Its Impact on Device‐Related Thrombosis and Arterial Thromboembolic Events

    • Authors: Kandi Zhang, Hanwen Yu, Yihua Lu, Peng Zhang, Dongsheng Liu, Jianpeng Huang, Jing Zhou, Yiqian Yuan, Zongqi Zhang, Qingyong Zhang et al.

    • Year: 2025

  • Clinical Characteristics and Biomarkers Feature Analysis Using a Proteomics Platform in Young Patients with Acute Coronary Syndrome

    • Authors: Zhang K, Wang F, Yu Q, Song Y, Gu J, He Q, Zhang J

    • Year: 2024

  • Angiopoietin-like Protein 2 Inhibits Thrombus Formation

    • Authors: Zhang T, Zhang M, Guo L, Liu D, Zhang K, Bi C, Zhang P, Wang J, Fan Y, He Q et al.

    • Year: 2024

  • Identification of Shared Molecular Mechanisms and Diagnostic Biomarkers Between Heart Failure and Idiopathic Pulmonary Fibrosis

    • Authors: Zhang P, Geng L, Zhang K, Liu D, Wei M, Jiang Z, Lu Y, Zhang T, Chen J, Zhang J

    • Year: 2024

  • AGK Potentiates Arterial Thrombosis by Affecting Talin-1 and αIIbβ3-Mediated Bidirectional Signaling Pathway

    • Authors: Zhang P, Jiang H, Yang M, Bi C, Zhang K, Liu D, Wei M, Jiang Z, Keyu Lv, Fang C et al.

    • Year: 2023

  • Role of GPR56 in Platelet Activation and Arterial Thrombosis

    • Authors: Liu D, Zhang P, Zhang K, Bi C, Li L, Xu Y, Zhang T, Zhang J

    • Year: 2022

  • Comparison of Multiple Imaging Modalities for Measuring Orifice Diameter and Selecting Occluder Size in Patients Undergoing Left Atrial Appendage Closure

    • Authors: Kandi Zhang, Jing Zhou, Tiantian Zhang, Zongqi Zhang, Shanliang Jin, Qing He, Junfeng Zhang

    • Year: 2022

  • Pretreatment with Antiplatelet Drugs Improves the Cardiac Function After Myocardial Infarction Without Reperfusion in a Mouse Model

    • Authors: Zhang K, Yang W, Zhang M, Sun Y, Zhang T, Liu J, Zhang J

    • Year: 2019

  • Paired Immunoglobulin-like Receptor B Regulates Platelet Activation

    • Authors: Fan X, Shi P, Dai J, Lu Y, Chen X, Liu X, Zhang K, Wu X, Sun Y, Wang K et al.

    • Year: 2014

Murtii Teressa Obolu | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Murtii Teressa Obolu | Medicine and Dentistry | Best Researcher Award

Corresponding Author from Hawassa university, Ethiopia

Dr. Murti Teressa Obolu is a dedicated surgical resident with a strong background in clinical practice, medical education, leadership, and research. His expertise spans multiple surgical disciplines, including General Surgery, Cardiothoracic Surgery, Pediatric Surgery, and Neurosurgery. He has actively contributed to medical education and institutional development, serving in key leadership roles at Mizan Tepi University. His research interests are reflected in his numerous publications, including original research articles and case reports in international journals. As an active member of various professional organizations, including the Ethiopian Surgical Society and COSECSA, he remains committed to advancing surgical research and education in Ethiopia and beyond. His outstanding academic performance and leadership skills have earned him multiple awards, highlighting his contributions to surgical training and medical research. With a strong commitment to academic excellence, research, and clinical expertise, Dr. Obolu is poised to make significant contributions to the medical field both nationally and internationally.

Professional Profile

Education

Dr. Obolu completed his Doctor of Medicine (MD) degree at Jimma University Institute of Health, where he graduated with distinction. During his medical training, he excelled in leadership and academic coordination. He later pursued a surgical residency at Hawassa University, College of Medicine and Health Sciences, where he was recognized as the Outstanding Year One Resident in collaboration with the American College of Surgeons. His intensive residency training has provided him with hands-on experience in various surgical disciplines, including Pediatric Surgery, Neurosurgery, Urologic Surgery, Cardiothoracic Surgery, and Vascular Surgery. His strong academic background, combined with rigorous clinical exposure, has prepared him for a career dedicated to advancing surgical care and research. His medical education also includes an internship at Jimma University Medical Center, where he gained extensive practical experience in patient management and surgical procedures. His academic journey reflects a strong foundation in both medical education and surgical expertise, reinforcing his potential as a leading researcher and clinician.

Professional Experience

Dr. Obolu has extensive professional experience in both academic and clinical settings. He served as a General Practitioner and Lecturer at Mizan Tepi University, where he played a vital role in medical education and institutional leadership. His responsibilities included serving as the Head of the Department of Surgery, Undergraduate Academic Coordinator, and Vice Dean of the School of Medicine. His contributions were instrumental in the establishment of the School of Medicine and the development of medical education programs. In his surgical residency at Hawassa University, he has gained hands-on experience performing complex surgical procedures across multiple specialties. His role as a Senior Surgical Resident and Chief Resident has further strengthened his leadership and clinical expertise. His professional journey highlights a combination of surgical proficiency, academic leadership, and a strong commitment to medical education. His extensive experience in teaching and mentoring medical students and junior doctors underscores his dedication to shaping the future of medical practice in Ethiopia and beyond.

Research Interest

Dr. Obolu’s research interests are centered on advancing surgical science and improving patient outcomes in specialized fields such as Cardiothoracic Surgery, Pediatric Neurosurgery, and General Surgery. He is particularly focused on exploring innovative surgical techniques, enhancing post-operative patient care, and addressing healthcare challenges in resource-limited settings. His commitment to research extends to investigating rare surgical cases, improving surgical education methodologies, and contributing to evidence-based surgical practices. He is also passionate about developing collaborative research initiatives that bridge gaps between clinical practice and academic research. Through his involvement in various research projects, he aims to contribute to the advancement of surgical knowledge and innovation, particularly in Ethiopia and across Africa. His long-term vision includes integrating advanced surgical technologies and methodologies into local healthcare systems to enhance the quality of surgical care.

Research Skills

Dr. Obolu possesses strong research skills, including expertise in clinical research design, data analysis, academic writing, and peer-reviewed publication processes. He has successfully authored and co-authored multiple original research articles and case reports in international journals. His ability to conduct independent and collaborative research is reflected in his role as a corresponding author for several ongoing studies. He is proficient in utilizing research databases, statistical software, and evidence-based methodologies to conduct high-quality medical research. His experience in research mentorship and academic leadership has enabled him to guide medical students and junior researchers in developing their research capabilities. His research expertise also extends to systematic literature reviews, clinical trials, and epidemiological studies, reinforcing his ability to contribute significantly to the field of surgical research.

Awards and Honors

Dr. Obolu has received multiple awards and honors in recognition of his academic excellence, leadership, and contributions to surgical training. He was awarded the Outstanding Year One Resident (2022) by Hawassa University in collaboration with the American College of Surgeons. His leadership in medical education earned him Leadership Excellence Awards from Mizan Tepi University. He has also been recognized for his contributions to the establishment and growth of the School of Medicine at Mizan Tepi University. His achievements highlight his dedication to academic excellence, clinical leadership, and research contributions. Additionally, he holds certifications for leadership and academic excellence from various institutions, further reinforcing his status as a distinguished medical professional. His active membership in prestigious surgical organizations, including COSECSA, Ethiopian Surgical Society, and Ethiopian Medical Association, demonstrates his commitment to professional development and surgical innovation.

Conclusion

Dr. Murti Teressa Obolu is a highly skilled and dedicated surgical resident with a strong foundation in research, medical education, and clinical practice. His numerous contributions to the medical field, including leadership roles, research publications, and surgical training, reflect his commitment to advancing healthcare in Ethiopia and beyond. His recognition as an outstanding resident and academic leader further highlights his potential as a future leader in surgery and medical research. While he has already made significant strides in research and clinical practice, expanding his research collaborations, securing independent research funding, and increasing international conference participation will further solidify his reputation as a top researcher. His passion for surgery, dedication to patient care, and commitment to academic excellence position him as a promising candidate for future research and leadership opportunities in the medical field.

Publications Top Notes

  1. Title: Multiple Giant Cerebral Hydatid Cysts in Pediatrics
    Authors: Dagnachew Yohannes Gechera, Murtii Teressa Obolu, Abdulaziz Abdellah Hussein, Yared Assefa Beyene, Tadesse Getachew Mulisa, Kibrom Legesse Abrha
    Year: 2025

  2. Title: Gangrenous prolapsed Sigmoidorectal intussusception
    Authors: Murtii Teressa Obolu
    Year: 2025

  3. Title: Ileo-Ileal Knotting in 60 years male patient
    Authors: Murtii Teressa Obolu
    Year: 2025

  4. Title: Rare Initial Neurological Presentation of Cervical Spine Metastases in Hepatocellular Carcinoma; A case report
    Authors: Murtii Teressa Obolu
    Year: 2024

  5. Title: Ileo-Ileal Knotting: A Case Report of a 60-Year-Old Male Patient in Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia
    Authors: Tewodros Tadesse, Abdullahi Mohamed Muhumed, Murtii Teressa Obolu, Gediyon Getachew Gebo
    Year: 2024

  6. Title: Appendico-Ileal Knotting: A Case Report of 17-Year-Old Female Patient in Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia
    Authors: Murtii Teressa, Tewodros Tadesse, Tadesse Getachow, Ermias Tadesse
    Year: 2024

  7. Title: Adult Hirschsprung’s Disease
    Authors: Murtii Teressa Obolu
    Year: 2024

  8. Title: SARS-CoV-2 Infections, Clinical Characteristics, and Related Risk Factors: The First 8 Months Surveillance Study Conducted in Southwest Ethiopia
    Authors: Dassalegn Muleta, Asnake Simieneh, Tadesse Duguma, Eyob Tekalign, Teshale Worku, Gizachew Ayele, Yayeh Melaku, Abdulrezak Nuri, Murtii Teressa, Adinew Belay, et al.
    Year: 2023

  9. Title: Detection of Mycobacterium tuberculosis using Gene Xpert-MTB/RIF assay among tuberculosis suspected patients at Mizan-Tepi University Teaching Hospital, Southwest Ethiopia: An institution-based cross-sectional study
    Authors: Mengistu Abayneh Sebsibe, Murtii Teressa, Sebsibe Tadesse
    Year: 2022

  10. Title: Acute respiratory infections (ARIs) and factors associated with their poor clinical outcome among children under-five years attending pediatric wards of public hospital in Southwest district of Ethiopia: A prospective observational cohort study
    Authors: Mengistu Abayneh Sebsibe, Dassalegn Muleta, Asnake Simieneh, Tadesse Duguma, Molla Asnake, Murtii Teressa, Biruk Endalkachew, Milkiyas Toru
    Year: 2022

  11. Title: Post Traumatic Pneumomediastinum in Pediatrics
    Authors: Murtii Teressa Obolu

 

Sheng Guan | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Sheng Guan | Medicine and Dentistry | Best Researcher Award

Director Physician from THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY, China

Dr. Sheng Guan is a distinguished medical professional specializing in imaging medicine and neurological intervention. He serves as the Director of the Department of Imaging Medicine and Interventional Medicine at the First Affiliated Hospital of Zhengzhou University and leads the Department of Neurological Intervention. Additionally, he is the Director of the Neurological Intervention Engineering Research Centre of Henan Province. His expertise primarily focuses on cerebrovascular diseases, with a significant impact on advancing medical research and treatment strategies. Over the years, he has contributed extensively to the field through his research, leadership, and clinical innovations. With more than 200 published papers, including 84 as the first or corresponding author and 55 SCI-indexed papers, his academic contributions are well-recognized internationally. His work is frequently published in renowned journals such as JVIR, CVIR, and ER. Dr. Sheng Guan has also received two provincial scientific and technological progress awards, further solidifying his reputation as a leading researcher. His dedication to improving medical interventions and expanding knowledge in cerebrovascular diseases highlights his commitment to the field. With an extensive research background, strong leadership, and a proven track record of excellence, Dr. Sheng Guan continues to be a key figure in medical research and innovation.

Professional Profile

Education

Dr. Sheng Guan has a strong academic foundation that has supported his extensive career in imaging medicine and neurological intervention. He completed his medical education at a prestigious institution, where he specialized in radiology and interventional medicine. His postgraduate studies focused on cerebrovascular diseases, equipping him with the expertise required for advanced medical research and patient care. Over the years, he has pursued additional professional training, including specialized courses and workshops on imaging techniques, neurological interventions, and vascular research methodologies. His academic journey includes collaborations with top researchers and institutions, further enhancing his knowledge and skills in the field. Dr. Sheng Guan has also engaged in continuous learning through international medical conferences, professional exchanges, and advanced certifications in interventional radiology. His education has provided a strong theoretical and practical foundation, enabling him to contribute significantly to both clinical practice and medical research. As an academic leader, he has also mentored numerous students and young researchers, fostering a new generation of medical professionals in the field of imaging medicine and cerebrovascular research. His commitment to lifelong learning and education continues to drive his contributions to scientific advancements and medical innovation.

Professional Experience

Dr. Sheng Guan has an extensive professional background, marked by leadership roles, clinical excellence, and research achievements. He is currently the Director of the Department of Imaging Medicine and Interventional Medicine at the First Affiliated Hospital of Zhengzhou University, where he leads a team of medical professionals in advancing imaging and neurological intervention techniques. Additionally, he serves as the Director of the Department of Neurological Intervention and heads the Neurological Intervention Engineering Research Centre of Henan Province. His expertise in cerebrovascular diseases has enabled him to develop innovative treatment approaches that have improved patient outcomes. Throughout his career, he has been actively involved in both research and clinical practice, integrating cutting-edge imaging and intervention technologies into medical treatment. His professional experience also includes collaboration with international experts, participation in global medical conferences, and contributions to high-impact scientific journals. Dr. Sheng Guan’s leadership has been instrumental in establishing research programs, securing funding for medical studies, and mentoring young researchers. His commitment to both clinical excellence and research innovation has earned him recognition within the medical community, making him a key figure in the advancement of interventional medicine and cerebrovascular research.

Research Interest

Dr. Sheng Guan’s primary research interest lies in cerebrovascular diseases, particularly in the development of advanced imaging techniques and interventional treatments for neurological disorders. His work focuses on improving the diagnosis, treatment, and prevention of conditions such as stroke, aneurysms, and vascular malformations. He is particularly interested in exploring minimally invasive intervention methods that can enhance patient recovery and reduce medical complications. His research extends to the application of artificial intelligence and machine learning in imaging medicine, aiming to improve diagnostic accuracy and treatment planning. Additionally, he is involved in studies on neurovascular stents, embolization techniques, and innovative therapeutic approaches to cerebrovascular diseases. Dr. Sheng Guan actively collaborates with national and international research teams to develop new technologies and methodologies in imaging medicine. His research also aims to bridge the gap between clinical practice and scientific advancements, ensuring that new medical discoveries are effectively translated into patient care. Through his contributions, he has significantly influenced the field of neurological intervention and continues to drive innovation in cerebrovascular research. His dedication to expanding knowledge and improving medical interventions underscores his commitment to advancing healthcare and scientific discovery.

Research Skills

Dr. Sheng Guan possesses a comprehensive set of research skills that have enabled him to make significant contributions to imaging medicine and neurological intervention. He is proficient in advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), and digital subtraction angiography (DSA), which are essential for diagnosing and treating cerebrovascular diseases. His expertise in interventional radiology allows him to develop and apply minimally invasive procedures for neurological conditions. Dr. Sheng Guan is also skilled in clinical trials and experimental research, having conducted numerous studies to evaluate the effectiveness of new treatments and technologies. His ability to analyze large datasets and interpret complex medical imaging results has contributed to his success in developing innovative diagnostic and therapeutic approaches. Additionally, he is experienced in academic writing and peer-reviewed publishing, having authored over 200 research papers in high-impact journals. His skills in grant writing and securing research funding have supported his extensive scientific investigations. Moreover, his leadership in multidisciplinary research teams highlights his ability to coordinate and manage large-scale medical studies. Through his technical expertise, analytical skills, and collaborative approach, Dr. Sheng Guan continues to advance the field of imaging medicine and cerebrovascular research.

Awards and Honors

Dr. Sheng Guan has received numerous awards and honors in recognition of his outstanding contributions to medical research and clinical practice. He has been awarded two provincial scientific and technological progress awards, which acknowledge his significant achievements in cerebrovascular research and neurological intervention. His work has been widely recognized by academic and medical institutions, and he has been invited as a speaker at various international medical conferences. Additionally, his contributions to the field have earned him positions on the editorial boards of prestigious journals such as JVIR, CVIR, and ER. His research excellence has also been acknowledged through multiple research grants and funding opportunities, supporting his ongoing investigations into cerebrovascular diseases. Dr. Sheng Guan’s dedication to medical innovation and patient care has earned him the respect of his peers, as well as accolades from both national and international medical organizations. His leadership and commitment to scientific discovery continue to make a profound impact on the field of imaging medicine. With a strong record of achievements and recognition, Dr. Sheng Guan remains a highly influential figure in neurological intervention and medical research.

Conclusion

Dr. Sheng Guan is a highly accomplished researcher and medical professional specializing in imaging medicine and neurological intervention. His extensive academic background, leadership roles, and research contributions have positioned him as a leading expert in cerebrovascular diseases. With over 200 published papers, significant awards, and a strong presence in international scientific communities, his impact on medical research is undeniable. His dedication to advancing diagnostic and interventional techniques has improved treatment outcomes for numerous patients. Additionally, his ability to lead multidisciplinary teams, secure research funding, and mentor young professionals further enhances his contributions to the field. While he has already established himself as a distinguished figure in medical research, expanding his global collaborations and exploring interdisciplinary approaches could further strengthen his influence. Dr. Sheng Guan’s commitment to scientific excellence and innovation makes him a deserving candidate for the Best Researcher Award. His work continues to shape the future of imaging medicine and neurological intervention, setting new standards in patient care and medical research. Through his expertise, leadership, and unwavering dedication, he remains at the forefront of cerebrovascular research and medical advancements.

Publication Top Notes

  • Title: Safety and efficacy of staged coiling followed by flow diverter in the treatment of ruptured intracranial aneurysms
    Authors: Y. Li, Yuanzhi; F. Fan, Feng; Z. Chen, Zhen; Y. Fu, Yu; S. Guan, Sheng
    Year: 2025

  • Title: Safety and efficacy of intrasaccular flow disruptor in intracranial aneurysms
    Authors: Y. Li, Yuanzhi; F. Fan, Feng; S. Guan, Sheng
    Year: 2025

  • Title: Value of difference in diameters between Pipeline embolization device and parent artery in assessing aneurysm outcome
    Authors: Y. Ma, Yajing; H. Zhang, Hang; C. Liu, Chao; S. Guan, Sheng; X. Guo, Xinbin
    Year: 2025

  • Title: Reconstructive Endovascular Treatment of Compensative-Flow–Related Posterior Circulation Aneurysms With Anterior Circulation Artery Occlusion
    Authors: T. Quan, Tao; X. Zhang, Xin; J. Li, Jinyi; C. Duan, Chuanzhi; S. Guan, Sheng
    Year: 2025

  • Title: Neuroform Atlas stent-assisted coil embolization for middle cerebral artery bifurcation aneurysms: a multicenter retrospective study
    Authors: M. Fan, Mengyan; J. Li, Jing; C. Duan, Chuanzhi; J. Zhang, Jiamei; S. Guan, Sheng
    Year: 2025

  • Title: A review of new advances in neuro-intervention
    Authors: X. Fu, Xiaojie; W. Gong, Wentao; S. Guan, Sheng
    Year: 2025

  • Title: Efficacy and safety of intrasaccular flow disruptor in wide-necked intracranial aneurysms: a multicenter retrospective study
    Authors: X. Zhang, Xiaowen; J. Li, Jing; X. Li, Xifeng; X. Zhang, Xin; S. Guan, Sheng
    Year: 2025
    Citations: 1

  • Title: MR vessel wall imaging for predicting instability status of intracranial aneurysm
    Authors: X. Ma, Xinmei; Q. Fu, Qichang; S. Xie, Shanshan; J. Cheng, Jingliang; S. Guan, Sheng
    Year: 2025

  • Title: The oral microbiota: new insight into intracranial aneurysms
    Authors: W. Gong, Wentao; H. Yu, Hairong; W. You, Wei; Y. Li, Youxiang; S. Guan, Sheng
    Year: 2025

  • Title: Diagnosis of intracranial aneurysms by computed tomography angiography using deep learning-based detection and segmentation
    Authors: W. You, Wei; J. Feng, Junqiang; J. Lu, Jing; Y. Jiang, Yuhua; Y. Wang, Yan
    Year: 2024
    Citations: 4

 

 

Weitao Man | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Weitao Man | Medicine and Dentistry | Best Researcher Award

Neurosurgeon From Tsinghua University, China

Dr. Weitao Man is a distinguished attending physician in neurosurgery and an associate researcher at Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China. His expertise spans various areas of neurosurgery, particularly focusing on spinal cord injury, neurodegenerative diseases, and neurophysiology. With a solid academic background and clinical experience, Dr. Man has contributed extensively to the advancement of neuroscientific research and clinical treatments, particularly through his innovative work on biomaterials and regenerative medicine. His clinical approach integrates cutting-edge research findings with a compassionate patient care model, making him a prominent figure in his field.

Professional Profile

Education

Dr. Man’s educational journey began at Southern Medical University in Guangzhou, China, where he earned his Bachelor of Clinical Medicine in 2012. He further pursued his passion for neurosurgery, completing a Master’s in Neurosurgery from Capital Medical University in 2015. In 2021, he obtained his Ph.D. in Medicine from Tsinghua University under the mentorship of Professor Guihuai Wang. His rigorous academic training has laid the foundation for his exceptional contributions to the field of neurosurgery, focusing on spinal cord injury and neuroregenerative medicine.

Professional Experience

Dr. Man has a broad and distinguished career in both clinical practice and research. Currently, he serves as an attending neurosurgeon and associate researcher at Beijing Tsinghua Changgung Hospital, a role he has held since 2023. His earlier experiences include a post-doctoral fellowship at Massachusetts General Hospital, Harvard Medical School, and residency positions in renowned hospitals such as Sanbo Brain Hospital and Beijing Tsinghua Changgung Hospital. His career reflects a blend of hands-on clinical work and high-level scientific investigation, contributing to advancements in the field of neurosurgery.

Research Interests

Dr. Man’s primary research interests lie in the areas of spinal cord injury, neurodegenerative diseases, and the development of innovative biomaterials for neurosurgery. He is particularly focused on the molecular mechanisms of microglial polarization and its role in spinal cord regeneration. His work also includes the development of hydrogels and biomimetic exosomes as potential therapies for spinal cord injury. Dr. Man’s research bridges the gap between basic science and clinical application, aiming to improve the quality of life for patients suffering from neurological disorders.

Research Skills

Dr. Man is skilled in a wide array of advanced research techniques, including molecular biology, tissue engineering, and biocompatible material development. He has experience in utilizing animal models for neurodegenerative disease research and spinal cord injury repair. His expertise also extends to advanced imaging techniques, such as ultrafast power Doppler imaging, and the development of innovative biomaterials like conductive hydrogels for neural interfaces. These skills, combined with his strong analytical background, enable him to contribute significantly to both experimental research and clinical applications.

Awards and Honors

Throughout his career, Dr. Man has received numerous accolades for his groundbreaking work in neurosurgery and neuroregenerative medicine. His work on neurodegenerative diseases, particularly Parkinson’s disease and spinal cord injury, has garnered attention in prestigious medical journals and conferences. Dr. Man’s ability to combine clinical expertise with pioneering research has earned him recognition both in China and internationally, including funding from the Natural Science Foundation of China and the Beijing Natural Science Foundation for his research on spinal cord injury regeneration.

Conclusion

Dr. Weitao Man is a highly accomplished neurosurgeon and researcher whose career reflects a profound commitment to advancing the field of neurosurgery. His combination of clinical expertise, cutting-edge research, and dedication to patient care makes him a leader in his field. Through his research on spinal cord injury, neurodegenerative diseases, and neuroregenerative therapies, Dr. Man continues to make significant contributions toward improving the outcomes for patients with neurological disorders. His work promises to shape the future of neurosurgery and regenerative medicine for years to come.

Publications Top Notes

  • Title: 3D Bioprinted Dynamic Bioactive Living Construct Enhances Mechanotransduction-Assisted Rapid Neural Network Self-Organization for Spinal Cord Injury Repair

    • Authors: J. Yang, K. Kim, Y. Liu, K. Yang, X. Wang

    • Year: 2025

  • Title: Electroacupuncture Ameliorated Locomotor Symptoms in MPTP-Induced Mice Model of Parkinson’s Disease by Regulating Autophagy via Nrf2 Signaling

    • Authors: J. Zhang, Z. Fu, F. Wen, X. Sun, Y. Huang

    • Year: 2025

Saverio Cinti | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Saverio Cinti | Medicine and Dentistry | Best Researcher Award

Scientific Director of the Obesity Center of the Polytechnic University of Marche from Polytechnic University of Marche, Italy

Prof. Saverio Cinti is a distinguished researcher and academic in the field of obesity, adipose tissue physiology, and human anatomy. With over 35 years of experience in medical research and education, he has made groundbreaking contributions to the understanding of fat biology, metabolism, and obesity-related disorders. He has served as a Full Professor of Human Anatomy at Marche Polytechnic University and is currently the Scientific Director of the Obesity Center at the same institution. His prolific research output includes over 340 peer-reviewed publications, with an impressive H-index of 87 and 37,585 citations (Scopus), demonstrating his global influence in the scientific community. He has also authored books, contributed to over 20 book chapters, and holds multiple patents in the field of metabolic diseases. Prof. Cinti has been an invited speaker at prestigious institutions, including Harvard, Columbia, NIH, and the European Congress of Endocrinology. His contributions have been recognized with prestigious awards, such as the Blaise Pascal Medal and the Friedrich Wassermann Prize. As a pioneer in adipose tissue research, his work continues to shape the future of obesity treatment and metabolic health on an international scale.

Professional Profile

Education

Prof. Saverio Cinti’s academic journey began with a Doctor of Medicine (MD) degree from the University of Padua in 1974. He then pursued specialization in Internal Medicine at the University of Verona (1979) and Surgical Pathology at the University of Milan (1982). His advanced training provided him with a strong foundation in human anatomy, cellular biology, and pathology, which later became central to his research on obesity and adipose tissue. Over the years, he has continuously expanded his expertise, engaging in multidisciplinary medical research and international collaborations. His education has been complemented by extensive teaching experience, particularly in anatomy, histology, and obesity-related metabolic studies. His deep understanding of human anatomy and pathology has allowed him to bridge the gap between basic research and clinical applications. His affiliation with global institutions, including the University of Copenhagen and the University of Bonn, further highlights his role as a leading educator and researcher in the field. His academic background, combined with his dedication to continuous learning, has positioned him as a key figure in obesity and metabolic disorder research.

Professional Experience

Prof. Cinti has held several prominent academic and research positions over the past four decades. From 1984 to 2020, he was the Head of the Anatomy and Cell Biology Unit at the Department of Experimental and Clinical Medicine at Marche Polytechnic University. He served as a Full Professor of Human Anatomy from 1986 to 2020, where he played a crucial role in shaping medical education. His leadership extends beyond academia, as he has also been the Director of the Obesity Center at Marche Polytechnic University since 2011 and the Scientific Director of the Obesity Center since 2020. His international experience includes being an Affiliated Professor at the University of Copenhagen and a Distinguished Professor Emeritus at the University of Bonn. Additionally, he has served as the President of the Italian Society of Obesity (SIO) from 2008 to 2010. His long-standing involvement in clinical research and academic leadership has significantly contributed to advancements in obesity and adipose tissue research. His career is marked by extensive grant funding (~€2.5 million), numerous high-impact publications, and collaborative efforts in obesity and metabolic disease research.

Research Interest

Prof. Cinti’s research primarily focuses on adipose tissue biology, obesity mechanisms, and metabolic disorders. His work has provided crucial insights into the function, differentiation, and plasticity of adipocytes, particularly in relation to metabolic diseases such as diabetes and obesity. He has extensively studied the role of white, brown, and beige adipose tissue in energy metabolism and thermogenesis. His research also explores the cellular and molecular mechanisms of fat storage, lipid metabolism, and the impact of obesity on systemic health. A key aspect of his work involves understanding how adipose tissue dysfunction contributes to metabolic syndrome, cardiovascular diseases, and inflammation-related disorders. He has been actively involved in translational research, bridging laboratory discoveries with potential clinical applications for obesity treatment. His studies on leptin, irisin, and adipose-derived stem cells have contributed to the development of innovative therapies for metabolic diseases. Additionally, his research extends to regenerative medicine, focusing on adipose tissue engineering for tissue repair and renewal. His contributions continue to shape obesity research, paving the way for novel therapeutic approaches and a better understanding of adipose tissue biology.

Research Skills

Prof. Cinti possesses a diverse range of research skills, making him a leading authority in obesity and adipose tissue studies. He is highly skilled in electron microscopy, histological analysis, and molecular biology techniques, which he has used to investigate the structure and function of adipose tissues. His expertise in cellular and molecular biology has allowed him to make groundbreaking discoveries regarding adipocyte differentiation and metabolic regulation. He is proficient in animal models of obesity, metabolic syndrome, and diabetes, enabling him to conduct preclinical research on obesity treatments. His work also involves biochemical assays, gene expression analysis, and imaging techniques to study fat metabolism and energy homeostasis. Additionally, he has experience in clinical research methodologies, including patient-based studies on obesity, metabolic disorders, and regenerative medicine. His strong background in scientific writing and peer reviewing has led to contributions in top-tier journals such as Nature, Science, and Cell Metabolism. His ability to integrate basic science with clinical applications has made him a pioneer in translational obesity research.

Awards and Honors

Prof. Cinti has received numerous prestigious awards in recognition of his contributions to obesity research. In 2008, he was awarded the Blaise Pascal Medal by the European Academy of Science, a prestigious honor for his pioneering work in metabolic diseases. In 2013, he received the Friedrich Wassermann Prize from the European Association for the Study of Obesity (EASO), further highlighting his impact on obesity research. He has also been honored as a Distinguished Professor Emeritus at the University of Bonn and has been a plenary speaker at international conferences, including Harvard, Columbia University, and the European Congress of Endocrinology. He has served as a peer reviewer for leading journals such as Science, Nature, and Cell Metabolism, further cementing his reputation as a global expert in obesity and metabolic disorders. His extensive contributions have also been recognized through significant research funding (~€2.5 million over the last decade) and multiple patents related to obesity treatment and metabolic health. These awards and honors reflect his exceptional influence in the scientific community.

Conclusion

Prof. Saverio Cinti is an internationally renowned researcher whose groundbreaking work in obesity and adipose tissue biology has significantly advanced the field. With an illustrious career spanning over four decades, he has contributed extensively through research, education, and leadership roles. His vast publication record, high citation impact, and numerous awards showcase his global influence. His research has led to new insights into fat metabolism, obesity treatment, and regenerative medicine, positioning him at the forefront of translational obesity research. His commitment to scientific excellence, combined with his mentorship and leadership roles, has inspired countless researchers worldwide. Moving forward, expanding interdisciplinary collaborations, integrating emerging technologies, and increasing public outreach could further enhance his already significant impact. Prof. Cinti’s contributions make him a strong candidate for the Best Researcher Award, reflecting his exceptional dedication to scientific progress and medical innovation.

Publications Top Notes

  • Title: A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
    Authors: P. Boström, J. Wu, M.P. Jedrychowski, A. Korde, L. Ye, J.C. Lo, K.A. Rasbach, …
    Year: 2012
    Citations: 5879

  • Title: Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1
    Authors: Z. Wu, P. Puigserver, U. Andersson, C. Zhang, G. Adelmant, V. Mootha, …
    Year: 1999
    Citations: 4936

  • Title: Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans
    Authors: S. Cinti, G. Mitchell, G. Barbatelli, I. Murano, E. Ceresi, E. Faloia, S. Wang, …
    Year: 2005
    Citations: 3248

  • Title: Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss
    Authors: R. Cancello, C. Henegar, N. Viguerie, S. Taleb, C. Poitou, C. Rouault, …
    Year: 2005
    Citations: 1498

  • Title: Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice
    Authors: P. Seale, H.M. Conroe, J. Estall, S. Kajimura, A. Frontini, J. Ishibashi, P. Cohen, …
    Year: 2011
    Citations: 1482

  • Title: Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice
    Authors: J. Lin, P.H. Wu, P.T. Tarr, K.S. Lindenberg, J. St-Pierre, C. Zhang, V.K. Mootha, …
    Year: 2004
    Citations: 1465

  • Title: The adipose organ
    Authors: S. Cinti
    Year: 2007
    Citations: 1161

  • Title: βAR signaling required for diet-induced thermogenesis and obesity resistance
    Authors: E.S. Bachman, H. Dhillon, C.Y. Zhang, S. Cinti, A.C. Bianco, B.K. Kobilka, …
    Year: 2002
    Citations: 1079

  • Title: Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch
    Authors: P. Cohen, J.D. Levy, Y. Zhang, A. Frontini, D.P. Kolodin, K.J. Svensson, J.C. Lo, …
    Year: 2014
    Citations: 967

  • Title: The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation
    Authors: G. Barbatelli, I. Murano, L. Madsen, Q. Hao, M. Jimenez, K. Kristiansen, …
    Year: 2010
    Citations: 948

  • Title: The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue
    Authors: M.C. Zingaretti, F. Crosta, A. Vitali, M. Guerrieri, A. Frontini, B. Cannon, …
    Year: 2009
    Citations: 915

  • Title: Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice
    Authors: I. Murano, G. Barbatelli, V. Parisani, C. Latini, G. Muzzonigro, M. Castellucci, …
    Year: 2008
    Citations: 879

 

Marjan Ghaemi | Medicine and Dentistry | Women Researcher Award

Published on by Shen Awards

Prof. Marjan Ghaemi | Medicine and Dentistry | Women Researcher Award

Prof Tehran university of medical sciences at Iran

Dr. Marjan Ghaemi is an accomplished gynecologist, obstetrician, and infertility specialist with a fellowship in endocrinology. She serves as an Assistant Professor at Vali-E-Asr Reproductive Health Research Center, Tehran University of Medical Sciences. With a strong background in both clinical and research fields, she has dedicated her career to advancing reproductive health. Her expertise spans infertility treatments, reproductive endocrinology, gynecological oncology, and minimally invasive surgery. Additionally, she has played a significant role in medical research and education, holding editorial positions in esteemed journals. Dr. Ghaemi has also contributed to digital health innovations, developing medical IT solutions and e-learning programs. With extensive experience in clinical research, trial management, and evidence-based medicine, she has been instrumental in improving reproductive healthcare. Her leadership in both academia and clinical practice has positioned her as a key figure in the field. Passionate about bridging the gap between research and patient care, she continues to explore new frontiers in reproductive medicine. Her contributions to gynecology and infertility research make her a strong contender for prestigious awards. She strives to integrate cutting-edge technology and medical advancements to enhance women’s healthcare, both nationally and internationally.

Professional Profile

Education

Dr. Marjan Ghaemi has an extensive educational background in medicine, gynecology, and reproductive endocrinology. She obtained her Doctorate in Medicine (MD) from Tehran University of Medical Sciences (TUMS), where she conducted research on the prevalence of polycystic ovary syndrome (PCOS) in adolescents. She further pursued specialization in obstetrics and gynecology at TUMS, achieving the highest national board exam score in OB/GYN in 2019. Her residency research focused on evaluating the quality of life in gynecological cancer patients using a web-based study. Dr. Ghaemi then completed a fellowship in infertility and endocrinology at TUMS, where she conducted a randomized controlled trial comparing different ovarian stimulation protocols in IVF patients with PCOS. Her educational achievements reflect her strong academic foundation and commitment to evidence-based medicine. With a focus on reproductive endocrinology, infertility treatments, and gynecological oncology, her research and clinical training have positioned her as a leader in her field. Her education not only provided her with deep clinical expertise but also honed her research skills, allowing her to contribute significantly to scientific advancements. Through her academic journey, she has consistently demonstrated excellence in both research and patient care, making significant contributions to reproductive medicine.

Professional Experience

Dr. Marjan Ghaemi has a distinguished professional career in clinical practice, academia, and research. She currently serves as an Assistant Professor at Vali-E-Asr Reproductive Health Research Center, TUMS, where she focuses on infertility treatments and reproductive endocrinology. She previously worked as an Assistant Professor at Kamali Hospital, Alborz University of Medical Sciences. Her expertise includes advanced infertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and minimally invasive gynecological surgeries. Dr. Ghaemi has also played a significant role in scientific publishing, serving as the Chief Editor of Fertility, Gynecology and Andrology and as an Associate Editor for the Journal of Family and Reproductive Health. Her research leadership extends to clinical trials and medical IT innovations. As a Clinical Research Manager at Farzan Clinical Research, she supervised multiple Phase II-IV studies and contributed to the development of digital health solutions, including e-learning platforms and medical applications. She has also worked extensively in hospital settings, managing complex cases in gynecology, obstetrics, and infertility. Her vast experience in research, patient care, and medical education makes her a well-rounded professional dedicated to advancing women’s health and reproductive medicine.

Research Interests

Dr. Marjan Ghaemi’s research focuses on reproductive endocrinology, infertility, and gynecological health. She has a particular interest in polycystic ovary syndrome (PCOS), exploring its prevalence, impact on fertility, and treatment options. Her work in in-vitro fertilization (IVF) has contributed to optimizing ovarian stimulation protocols, improving success rates for women with infertility. She is also interested in recurrent pregnancy loss and male infertility, expanding her research to encompass both partners in reproductive challenges. Additionally, Dr. Ghaemi has investigated the quality of life in gynecological cancer patients, seeking ways to enhance supportive care. Her research extends to hormonal therapies, reproductive surgeries, and minimally invasive techniques, contributing to advancements in assisted reproductive technology (ART). Another key area of her work involves the integration of digital health in reproductive medicine, including e-learning platforms and telemedicine for patient education. She is passionate about bridging the gap between clinical practice and research, ensuring that scientific advancements translate into better patient outcomes. Her multidisciplinary approach combines clinical expertise with innovative research methodologies, making her a leader in reproductive medicine. Through her studies, she aims to improve fertility treatments and reproductive health care, benefiting both patients and the scientific community.

Research Skills

Dr. Marjan Ghaemi possesses advanced research skills in clinical trials, reproductive endocrinology, and gynecological health. She is proficient in designing and conducting randomized controlled trials (RCTs), as demonstrated in her research on ovarian stimulation protocols in IVF. She has extensive experience in medical research methodologies, data analysis, and evidence-based practice. Her expertise in site monitoring, project management, and medical reporting has made her a key contributor to clinical research studies. Additionally, she has strong skills in digital health and medical IT, having developed e-learning platforms, mobile health applications, and smart e-health projects. Dr. Ghaemi’s editorial roles in leading medical journals have enhanced her abilities in scientific publishing, peer review, and manuscript editing. She is also skilled in medical writing and literature reviews, ensuring high-quality contributions to academic publications. Her experience in biostatistics and research ethics allows her to conduct rigorous and ethically sound studies. Furthermore, she has expertise in advanced imaging techniques such as gynecological and infertility ultrasound, enhancing her research capabilities in diagnostic medicine. Her diverse skill set in clinical and digital research makes her a valuable figure in reproductive medicine, contributing to scientific advancements and improved patient care.

Awards and Honors

Dr. Marjan Ghaemi has received several awards and honors in recognition of her academic excellence and contributions to reproductive medicine. She achieved the highest national board exam score in OB/GYN in 2019, demonstrating her outstanding medical knowledge and expertise. Her research on polycystic ovary syndrome (PCOS) and infertility treatments has been acknowledged in various academic and clinical circles. She has also played a pivotal role in medical research and journal editing, earning recognition for her editorial leadership in Fertility, Gynecology and Andrology and Journal of Family and Reproductive Health. As a Clinical Research Manager at Farzan Clinical Research, she was part of a team that earned national recognition as a top knowledge-based institute. Additionally, her contributions to medical IT and e-learning have been praised, as she has led projects in digital health solutions for reproductive medicine. Her work in gynecological cancer quality-of-life studies has also been highlighted in medical research communities. With her achievements in academia, research, and digital innovation, Dr. Ghaemi continues to be recognized as a leading figure in reproductive health and infertility research, making significant contributions to the field.

Conclusion

Dr. Marjan Ghaemi is an exceptional researcher and clinician in reproductive medicine, with expertise spanning gynecology, infertility, and endocrinology. Her contributions to clinical research, medical education, and digital health innovation have positioned her as a leader in the field. With a strong academic background, she has conducted impactful research on PCOS, IVF, and gynecological health, improving fertility treatment outcomes. Her editorial roles in leading journals further emphasize her dedication to advancing scientific knowledge. She has also played a key role in integrating digital health solutions into reproductive medicine, enhancing patient education and research methodologies. While she has achieved significant milestones, expanding her international collaborations and high-impact publications could further elevate her global presence. Overall, her dedication to evidence-based medicine and patient-centered care makes her a strong candidate for prestigious research awards. Dr. Ghaemi’s work is instrumental in shaping the future of reproductive health, and she remains committed to pioneering advancements in infertility treatments and women’s healthcare. With her expertise, leadership, and passion for research, she continues to make remarkable contributions to medical science and patient well-being.

Publications Top Notes

  1. Title: Uterus transplantation: A bibliometric review of six-decade study from 1960 to 2024
    Authors: R. Akbari, M. Ghaemi, Z.Y. Panahi
    Year: 2025
    Citations: 1

  2. Title: The Effectiveness of Letrozole Alone or in Combination with Methotrexate in the Management of Ectopic Pregnancy, A Systematic Review and Meta-Analysis
    Authors: A.M. Tarafdari, F. Keikha, F. Asadi, M. Forouzin, M. Ghaemi
    Year: 2024

  3. Title: Knowledge, attitudes, and practices of healthcare providers among women oncofertility in Iran: a cross-sectional study
    Authors: M. Ghaemi, I. Rokhzadi, M. Dashtkoohi, N. Eshraghi, M. Fakehi
    Year: 2024

  4. Title: Potential efficacy of digital polymerase chain reaction for non-invasive prenatal screening of autosomal aneuploidies: a systematic review and meta-analysis
    Authors: M. Parsaei, M. Dashtkoohi, T. Salmani, M. Ghaemi, S. Hantoushzadeh
    Year: 2024

  5. Title: The association between increased fetal movements in the third trimester and perinatal outcomes; a systematic review and meta-analysis
    Authors: S. Hantoushzadeh, O. Kohandel Gargari, M. Jamali, Z. Panahi, G.R. Habibi
    Year: 2024

  6. Title: Breast Implant Illness as a Challenging Disorder in Clinics
    Authors: F.G. Vahdani, M. Ghaemi, M. Haddadi
    Year: 2024

  7. Title: The association between the amount of fetal fraction in cell-free DNA testing and adverse pregnancy outcomes: A cohort study
    Authors: M. Aryavand, M. Noorzadeh, M. Ghaemi, S.E. Delfan, V. Marsoosi
    Year: 2024

  8. Title: Analysis of medico-legal claims related to deliveries: Caesarean section vs. vaginal delivery
    Authors: N. Eshraghi, M. Ghaemi, Z. Shabannejad, Z. Mansouri, S. Hantoushzadeh
    Year: 2024
    Citations: 1

  9. Title: The effect of Myo-inositol on improving sperm quality and IVF outcomes: A systematic review and meta-analysis
    Authors: M. Ghaemi, N. Seighali, A. Shafiee, Z.Y. Panahi, S. Hantoushzadeh
    Year: 2024
    Citations: 1

 

 

Wei Zhang | Health Professions | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Wei Zhang | Health Professions | Best Researcher Award

Professor at School of Nursing, Jilin University, China

Dr. Zhang Wei is a distinguished professor at Jilin University’s School of Nursing, where she leads the Department of Obstetrics and Gynecology Nursing. Her extensive career encompasses significant contributions to maternal and child health nursing, mental health nursing, and nursing education. Dr. Zhang has published over 40 papers as the first or corresponding author, with more than 30 in SCI-indexed journals, underscoring her commitment to advancing nursing science.

Professional Profile

Education

Dr. Zhang’s academic journey began with a bachelor’s degree in Maternal and Child Health from Jilin University’s Norman Bethune College of Medicine in 2002. She then earned a master’s degree in Women’s Health from the same institution in 2005. Pursuing further specialization, she obtained her Ph.D. in Immunology from Jilin University’s First Hospital in 2012. Demonstrating a commitment to interdisciplinary research, Dr. Zhang completed a postdoctoral fellowship in Social Medicine and Health Management at Jilin University’s School of Public Health between 2015 and 2021.

Professional Experience

Dr. Zhang’s professional trajectory at Jilin University is marked by progressive academic appointments. She began as a teaching assistant in the School of Nursing in 2005, advanced to lecturer in 2008, and was promoted to associate professor in 2014. In September 2023, she achieved the rank of professor. Throughout her tenure, Dr. Zhang has been instrumental in curriculum development and has served on both the Academic and Teaching Committees of the School of Nursing.

Research Interests

Dr. Zhang’s research interests are diverse and impactful. She focuses on maternal and child health nursing, emphasizing health promotion and care for women during critical life stages such as pregnancy, perimenopause, and adolescence. Her work in mental health nursing addresses psychological well-being, while her studies in chronic disease management concentrate on nursing care and preventive measures for female reproductive system cancers, including breast and gynecological tumors. Additionally, Dr. Zhang is dedicated to nursing education, exploring innovative teaching models and methods, particularly in blended learning environments.

Research Skills

Dr. Zhang possesses a robust set of research skills, including proficiency in systematic reviews and meta-analyses, as evidenced by her publications on topics like the effectiveness of family-centered interventions for caregivers and internet-based cognitive behavioral therapy for cancer patients. She is adept at both qualitative and quantitative research methodologies, enabling her to conduct comprehensive studies that inform evidence-based nursing practices.

Awards and Honors

Throughout her career, Dr. Zhang has received numerous accolades recognizing her contributions to nursing education and research. Notably, she was awarded the third prize in the 17th Jilin Province Higher Education Scientific Research Achievement Awards in November 2022 for her work on blended teaching models in obstetrics and gynecology nursing. She also received the Excellence Award for Undergraduate “Classroom Teaching Quality” at Jilin University for the 2021-2022 academic year, reflecting her dedication to teaching excellence.

Conclusion

Dr. Zhang Wei’s exemplary career in nursing is characterized by her unwavering commitment to advancing healthcare through research, education, and leadership. Her multidisciplinary expertise and dedication to improving women’s health have significantly impacted both the academic community and clinical practice. Dr. Zhang continues to inspire future generations of nurses and healthcare professionals through her innovative work and steadfast dedication to the field.

Publication Top Notes

  1. “Effectiveness of Meaning-Centered Interventions on Existential Distress and Mental Health Outcomes in Cancer Survivors and Their Family Caregivers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
    • Authors: Ziqi Wang, Dongsheng Xu, Shuanghan Yu, Yantong Liu, Yujie Han, Wei Zhao, Wei Zhang
    • Year: 2025
    • Journal: Worldviews on Evidence-Based Nursing
  2. “Effects of Nurse-Led e-Health Interventions on the Health-Related Outcomes of Pregnant Women: A Systematic Review”
    • Authors: Yujie Han, Qi Tian, Mengmeng Xu, Ziqi Wang, Wei Zhang
    • Year: 2025
    • Journal: Journal of Clinical Nursing
  3. “The Impact of Simulation-Based Learning on Nursing Decision-Making Ability: A Meta-Analysis”
    • Authors: Wei Zhao, Mengmeng Xu, Qi Tian, Ziqi Wang, Wei Zhang
    • Year: 2024
    • Journal: Clinical Simulation in Nursing
  4. “Effectiveness of Family-Centered Interventions for Family Caregivers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
    • Authors: Ziqi Wang, Shuanghan Yu, Yantong Liu, Yujie Han, Wei Zhao, Wei Zhang
    • Year: 2024
    • Journal: Journal of Clinical Nursing
    • Citations: 2